Evidence map›Paper›PMID 29976229›Full record

ArticleBreast cancer research : BCR2018

Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.

Colleen Chute, Xinhai Yang, Kristy Meyer, Ning Yang, Keelin O'Neil, Ildiko Kasza, Kevin Eliceiri, Caroline Alexander, Andreas Friedl

Open access · goldAbstract read
In one paragraph

Article in Breast cancer research : BCR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. SDC1 is a critical transmembrane proteoglycan in breast cancer.World journal of surgical oncology · 2025
    Review
  7. Article
  8. Article
  9. Single-cell transcriptome analysis of the mouse lungs during the injury and recovery periods after lipopolysaccharide administration.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Colleen ChuteDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 6051 WIMR, MC-2275, 1111 Highland Avenue, Madison, WI, 53705, USA.
Xinhai YangDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 6051 WIMR, MC-2275, 1111 Highland Avenue, Madison, WI, 53705, USA.
Kristy MeyerDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 6051 WIMR, MC-2275, 1111 Highland Avenue, Madison, WI, 53705, USA.
Ning YangDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 6051 WIMR, MC-2275, 1111 Highland Avenue, Madison, WI, 53705, USA.
Keelin O'NeilDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 6051 WIMR, MC-2275, 1111 Highland Avenue, Madison, WI, 53705, USA.
Ildiko KaszaDepartment of Oncology, University of Wisconsin-Madison, Madison, WI, USA.
Kevin EliceiriUniversity of Wisconsin Carbone Cancer Center, Madison, WI, USA.
Caroline AlexanderUniversity of Wisconsin Carbone Cancer Center, Madison, WI, USA.
Andreas FriedlDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, 6051 WIMR, MC-2275, 1111 Highland Avenue, Madison, WI, 53705, USA. afriedl@wisc.edu.ORCID 0000-0001-9027-0167
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
Syndecan-1 in Stromal Fibroblasts of Breast CarcinomasR01CA107012 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI FRIEDL, ANDREAS · 2005 to 2014
$2.8M
STATs as Key Targets in Tumor AngiogenesisI01BX000137 · VA · WM S. MIDDLETON MEMORIAL VETERANS HOSP · PI FRIEDL, ANDREAS · 2009 to 2016
–
BLRD VA I01 BX000137NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA107012
6 · The paper itself

Abstract

backgroundSyndecan-1 (Sdc1), a cell surface heparan sulfate proteoglycan normally expressed primarily by epithelia and plasma cells, is aberrantly induced in stromal fibroblasts of breast carcinomas. Stromal fibroblast-derived Sdc1 participates in paracrine growth stimulation of breast carcinoma cells and orchestrates stromal extracellular matrix fiber alignment, thereby creating a migration and invasion-permissive microenvironment. Here, we specifically tested the role of stromal Sdc1 in metastasis.

methodsThe metastatic potential of the aggressive mouse mammary carcinoma cell lines, 4T1 and E0776, was tested in wild-type and genetically Sdc1-deficient host animals. Metastatic lesions were characterized by immunohistochemical analysis.

resultsAfter orthotopic inoculation, the lung metastatic burden was reduced in Sdc1-/- animals by 97% and more than 99%, in BALB/cJ and C57BL/6 animals, respectively. The difference in metastatic efficiency was maintained when the tumor cells were injected into the tail vein, suggesting that host Sdc1 exerts its effect during later stages of the metastatic cascade. Co-localization studies identified Sdc1 expression in stromal fibroblasts within the metastatic microenvironment and in normal airway epithelial cells but not in other cells (endothelial cells, α-smooth muscle actin positive cells, leucocytes, macrophages). The Ki67 proliferation index and the rate of apoptosis of the metastatic tumor cells were diminished in Sdc1-/- vs. Sdc1+/+ animals, and leucocyte density was indistinguishable. Sdc1-mediated metastatic efficiency was abolished when the animals were housed at a thermoneutral ambient temperature of 31 °C, suggesting that the host Sdc1 effect on metastasis requires mild cold stress.

conclusionsIn summary, Sdc1 is induced in the lung microenvironment after mammary carcinoma cell dissemination and promotes outgrowth of metastases in a temperature-dependent manner.

Indexed as

AnimalsApoptosisBreast NeoplasmsCell Line, TumorCell ProliferationEpithelial CellsFemaleFibroblastsGene Expression Regulation, NeoplasticHumansLung NeoplasmsMammary Neoplasms, AnimalMiceNeoplasm MetastasisSyndecan-1Tumor MicroenvironmentSyndecan-1Breast cancerExtracellular matrixMetastasisProteoglycansSyndecanTumor microenvironment

Identifiers

PMID29976229
PMCPMC6034333
OpenAlexW2870834822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.